After attending this educational session clinicians will:

--Describe the use of COVID pre-exposure prophylaxis in immunocompromised patients
--Accurately identify and prescribe  medication for COVID pre-exposure prophylaxis to patients who are candidates
--Perform expert counseling and education to patients who are candidates for COVID pre-exposure  prophylaxis

 

Catherine Silva, MD, Presenter, has no relevant financial relationships to disclose.

Jaime Gallegos, MD, Presenter, has no relevant financial relationships to disclose

Kelly Hennessy, NP, Presenter, has no relevant financial relationships to disclose

Faculty Member do plan to discuss investigational uses of a product: tixagavimab/cilgavimab monoclonal antibody pre exposure prophylaxis for COVID, under EUA. And monoclonal antibody tixagavimab/cilgavimab

Session date: 
06/14/2022 - 12:00pm to 1:00pm EDT
Location: 
Boston University Medical Center
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.